These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
389 related items for PubMed ID: 16368092
1. Toxoplasma gondii: DNA vaccination with bradyzoite antigens induces protective immunity in mice against oral infection with parasite cysts. Nielsen HV, Di Cristina M, Beghetto E, Spadoni A, Petersen E, Gargano N. Exp Parasitol; 2006 Apr; 112(4):274-9. PubMed ID: 16368092 [Abstract] [Full Text] [Related]
2. A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts. Beghetto E, Nielsen HV, Del Porto P, Buffolano W, Guglietta S, Felici F, Petersen E, Gargano N. J Infect Dis; 2005 Feb 15; 191(4):637-45. PubMed ID: 15655789 [Abstract] [Full Text] [Related]
3. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis. Dziadek B, Gatkowska J, Brzostek A, Dziadek J, Dzitko K, Grzybowski M, Dlugonska H. Vaccine; 2011 Jan 17; 29(4):821-30. PubMed ID: 21087690 [Abstract] [Full Text] [Related]
4. Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential. Dautu G, Munyaka B, Carmen G, Zhang G, Omata Y, Xuenan X, Igarashi M. Exp Parasitol; 2007 Jul 17; 116(3):273-82. PubMed ID: 17379212 [Abstract] [Full Text] [Related]
14. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice. Peng GH, Yuan ZG, Zhou DH, He XH, Liu MM, Yan C, Yin CC, He Y, Lin RQ, Zhu XQ. Vaccine; 2009 Nov 05; 27(47):6570-4. PubMed ID: 19720368 [Abstract] [Full Text] [Related]
15. The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection. Di Cristina M, Del Porto P, Buffolano W, Beghetto E, Spadoni A, Guglietta S, Piccolella E, Felici F, Gargano N. Microbes Infect; 2004 Feb 05; 6(2):164-71. PubMed ID: 14998514 [Abstract] [Full Text] [Related]
16. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii. Xue M, He S, Cui Y, Yao Y, Wang H. Parasitol Int; 2008 Dec 05; 57(4):424-9. PubMed ID: 18562245 [Abstract] [Full Text] [Related]
17. Protective effects of immunization with a recombinant cyst antigen in mouse models of infection with Toxoplasma gondii tissue cysts. Parmley S, Slifer T, Araujo F. J Infect Dis; 2002 Feb 15; 185 Suppl 1():S90-5. PubMed ID: 11865445 [Abstract] [Full Text] [Related]
19. Primary culture of skeletal muscle cells as a model for studies of Toxoplasma gondii cystogenesis. Guimarães EV, de Carvalho L, Barbosa HS. J Parasitol; 2008 Feb 15; 94(1):72-83. PubMed ID: 18372624 [Abstract] [Full Text] [Related]